MedPath

The effectiveness of intravenous Lidocaine versus Morphine in pain management in acute critical limb ischemia

Early Phase 1
Conditions
acute pain in critical limb ischemia.
Arterial embolism and thrombosis
Registration Number
IRCT201210148872N2
Lead Sponsor
Tehran University of Medical Sciences -Faculty of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Inclusion Criteria: having clinical signs and symptoms of acute critical limb ischemia which are known with 5P (Pain-paralysis – pulselessness- paresthesia- pallor) and is diagnosed by an emergency medicine specialist. Consent to join in the study is required and the form is read and signed by each one of the patients.
Exclusion criteria: contraindications of lidocaine and morphine: lung problems (including acute asthma; pulmonary edema); Heart conditions(including heart failure; cardiogenic shock; Block degree three; arrhythmia WPW and Stoke Adams syndrome); neurological problems(including seizures; changes in state of consciousness); chronic pain in another site; pregnancy; use of pain killers in recent week; allergy to lidocaine or morphine; addiction; prescription of opioid drugs intravenously by EMS or triage nurses; respiratory distress; blood pressure <100mmhg; trauma; altered level of consciousness; language problems and dementia.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain scoring. Timepoint: 0-15-30 Min after the begining of study. Method of measurement: visual analogue scale.
Secondary Outcome Measures
NameTimeMethod
Side effect. Timepoint: 0-15-30 min after the begining of study. Method of measurement: by name.;Blood pressure. Timepoint: 0-15-30 min after the begining of study. Method of measurement: mm/hg.;Heart rate. Timepoint: 0-15-30 min after the begining of study. Method of measurement: beats per min.;Pulse oximetry. Timepoint: 0-15-30 min after the begining of study. Method of measurement: %.
© Copyright 2025. All Rights Reserved by MedPath